Physician

Internal Medicine

Dr. Harold P. Koeffler, MD

Harold Koeffler works in the field of Internal Medicine. He studied medicine at Baylor College of Medicine. Harold Koeffler is also a published physician. He has 28 publication published. The most recent publication is: Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.

Publications

Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.
Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancer.
KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
Targeting genetic lesions in esophageal cancer.
KPT-330 has antitumour activity against non-small cell lung cancer.
The genomic landscape of nasopharyngeal carcinoma.
LNK (SH2B3): paradoxical effects in ovarian cancer.
Genomic and molecular characterization of esophageal squamous cell carcinoma.
Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Genetic differences between Asian and Caucasian chronic lymphocytic leukemia.
SH2B3 (LNK) mutations from Myeloproliferative Neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.
Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF).
Genomic characterization of human and rat prolactinomas.
Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis.
Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and...
Differentiation therapy of leukemia: 3 decades of development.
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.
Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.
Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.
Synthesis and Characterization of Novel 2-Amino-Chromene-Nitriles that Target Bcl-2 in Acute Myeloid Leukemia Cell Lines.
Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR-/- Mice.
Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival.
Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women.

Schools

Baylor College Of Medicine
Usc Med Center
University Of California Los Angeles

Doctors Specialties

Internal Medicine

Accepted Insurances

Education

UCLA Medical Center
University of Southern California - LAC+USC Medical Center
Baylor College of Medicine

Hospital

Cedars-Sinai Medical Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Mona Sabeti Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. David J. Kanani, MD This Doctor is OpenDoctor Recommended.
	Dr. Lizhou Huang, MD
	Dr. John C. Lin, MD
	Dr. Connie H. Lin, MD
	Dr. Christopher T. VanIchsarn, MD This Doctor is OpenDoctor Recommended.
	Dr. Omer P. Shah, MD This Doctor is OpenDoctor Recommended.
	Dr. Allison M. Mays, MD
	Dr. Christopher C. Shepherd, MD This Doctor is OpenDoctor Recommended.
	Dr. Gary I. Gutkin, MD This Doctor is OpenDoctor Recommended.